Every one of those 1 sits in a single category, market-trends. Bristol Myers Squibb is most often covered alongside Campbell Soup, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Bristol Myers Squibb
Every one of those 1 sits in a single category, market-trends. Bristol Myers Squibb is most often covered alongside Campbell Soup, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3 across the same-window beat baseline. The 6 average consequence score is below the beat benchmark of 6.9 in the same window. Bristol Myers Squibb appears in 1 tracked Startup story from June 15, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Bristol Myers Squibb. Shared-story counts are live from our verified record — not editorial picks.
Marvell Technology’s S&P 500 inclusion highlights a $1 trillion AI infrastructure opportunity, signaling massive exit potential for deep tech startups in semiconductors and AI. Flex’s addition reflects manufacturing tech’s maturation. This index shakeup underscores sectors where venture capital is chasing the next big hidden gem.